A single arm trial using passive simulated jogging for blunting acute hyperglycemia
Abstract Glycemic fluctuations increase oxidative stress, promote endothelial dysfunction and cardiovascular disease. Reducing glycemic fluctuations is beneficial. We previously reported that a portable motorized passive simulated jogging device, (JD) reduces 24 h glycemic indices in type 2 and non-...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a53d74f7faa4e7c813cd0f2b4cdacdb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0a53d74f7faa4e7c813cd0f2b4cdacdb |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0a53d74f7faa4e7c813cd0f2b4cdacdb2021-12-02T11:39:33ZA single arm trial using passive simulated jogging for blunting acute hyperglycemia10.1038/s41598-021-85579-72045-2322https://doaj.org/article/0a53d74f7faa4e7c813cd0f2b4cdacdb2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85579-7https://doaj.org/toc/2045-2322Abstract Glycemic fluctuations increase oxidative stress, promote endothelial dysfunction and cardiovascular disease. Reducing glycemic fluctuations is beneficial. We previously reported that a portable motorized passive simulated jogging device, (JD) reduces 24 h glycemic indices in type 2 and non-diabetic subjects. This study evaluates effectiveness and feasibility of JD in blunting large glycemic fluctuation induced by an oral glucose tolerance test (OGTT). The study was performed in 10 adult participants mean age 41.3 ± 13.5 year using interstitial glucose monitor (IG). Each participant fasted for 8 h. followed by an OGTT (Pre-JD), thereafter JD was used for 90 min per day for 7 days, without change to diet or activities of daily living. A repeat OGTT (Post-JD) was performed after completion. The integrated area under the curve (iAUC2h–4h) was computed for the OGTT Pre-JD and Post-JD. Seven days of JD blunted the glucose fluctuation produced by OGTT. JD decreased AUC2h by 17 ± 4.7% and iAUC4h by 15 ± 5.9% (p < 0.03). In healthy mostly obese participants 7 days of JD blunts the hyperglycemic response produced by an OGTT. JD may be an adjunct to current glycemic management, it can be applied in different postures for those who cannot (due to physical or cognitive limitations) or will not exercise. Trial registration: ClinicalTrials.gov NCT03550105 (08-06-2018).Jose A. AdamsJose R. LopezVeronica BanderasMarvin A. SacknerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Jose A. Adams Jose R. Lopez Veronica Banderas Marvin A. Sackner A single arm trial using passive simulated jogging for blunting acute hyperglycemia |
description |
Abstract Glycemic fluctuations increase oxidative stress, promote endothelial dysfunction and cardiovascular disease. Reducing glycemic fluctuations is beneficial. We previously reported that a portable motorized passive simulated jogging device, (JD) reduces 24 h glycemic indices in type 2 and non-diabetic subjects. This study evaluates effectiveness and feasibility of JD in blunting large glycemic fluctuation induced by an oral glucose tolerance test (OGTT). The study was performed in 10 adult participants mean age 41.3 ± 13.5 year using interstitial glucose monitor (IG). Each participant fasted for 8 h. followed by an OGTT (Pre-JD), thereafter JD was used for 90 min per day for 7 days, without change to diet or activities of daily living. A repeat OGTT (Post-JD) was performed after completion. The integrated area under the curve (iAUC2h–4h) was computed for the OGTT Pre-JD and Post-JD. Seven days of JD blunted the glucose fluctuation produced by OGTT. JD decreased AUC2h by 17 ± 4.7% and iAUC4h by 15 ± 5.9% (p < 0.03). In healthy mostly obese participants 7 days of JD blunts the hyperglycemic response produced by an OGTT. JD may be an adjunct to current glycemic management, it can be applied in different postures for those who cannot (due to physical or cognitive limitations) or will not exercise. Trial registration: ClinicalTrials.gov NCT03550105 (08-06-2018). |
format |
article |
author |
Jose A. Adams Jose R. Lopez Veronica Banderas Marvin A. Sackner |
author_facet |
Jose A. Adams Jose R. Lopez Veronica Banderas Marvin A. Sackner |
author_sort |
Jose A. Adams |
title |
A single arm trial using passive simulated jogging for blunting acute hyperglycemia |
title_short |
A single arm trial using passive simulated jogging for blunting acute hyperglycemia |
title_full |
A single arm trial using passive simulated jogging for blunting acute hyperglycemia |
title_fullStr |
A single arm trial using passive simulated jogging for blunting acute hyperglycemia |
title_full_unstemmed |
A single arm trial using passive simulated jogging for blunting acute hyperglycemia |
title_sort |
single arm trial using passive simulated jogging for blunting acute hyperglycemia |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/0a53d74f7faa4e7c813cd0f2b4cdacdb |
work_keys_str_mv |
AT joseaadams asinglearmtrialusingpassivesimulatedjoggingforbluntingacutehyperglycemia AT joserlopez asinglearmtrialusingpassivesimulatedjoggingforbluntingacutehyperglycemia AT veronicabanderas asinglearmtrialusingpassivesimulatedjoggingforbluntingacutehyperglycemia AT marvinasackner asinglearmtrialusingpassivesimulatedjoggingforbluntingacutehyperglycemia AT joseaadams singlearmtrialusingpassivesimulatedjoggingforbluntingacutehyperglycemia AT joserlopez singlearmtrialusingpassivesimulatedjoggingforbluntingacutehyperglycemia AT veronicabanderas singlearmtrialusingpassivesimulatedjoggingforbluntingacutehyperglycemia AT marvinasackner singlearmtrialusingpassivesimulatedjoggingforbluntingacutehyperglycemia |
_version_ |
1718395683756572672 |